Tilray Brands, Inc. - Common Stock (TLRY)

Washington D.C. – December 12, 2025 – In a move sending seismic waves through the financial markets, President Donald Trump is reportedly poised to enact a landmark reclassification of marijuana, shifting it from a Schedule I to a Schedule III controlled substance under federal law. The news, which broke late on

President Trump is reportedly expected to issue an executive order as soon as Monday allowing for reclassification of marijuana.

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 40.8% in the afternoon session after reports suggested the Trump administration planned to ease federal restrictions on marijuana by reclassifying it as a less dangerous substance. 

Here are the top movers in Friday's session, showcasing the stocks with significant price changes.

Broadcom shares were down more than 11% in Friday’s midday session after CEO Hock Tan’s $73 billion AI backlog order statement failed to impress Wall Street.

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

President Trump just delivered an early Christmas gift to Tilray.

Tilray shares are trading higher Friday following a report suggesting Trump is expected to reclassify marijuana as a Schedule III drug.

Cannabis stocks surge on rare one-two punch: Trump hinting at reclassification, and Tilray's successful vape launch.

Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

The stock prices of major cannabis companies like skyrocketed n premarket trading on Friday, following reports of Trump easing Federal rules.

As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

While the Dow Jones futures were up on Friday morning, S&P and Nasdaq 100 futures were down.

U.S. stock futures swung between gains and losses on Friday after Thursday’s mixed close. Futures of major benchmark indices were mixed.

The cannabis industry is enjoying renewed momentum under Trump, whose administration has adopted a notably more accommodative approach toward the drug and its related products.

Tilray Brands shares surged in after-hours trading following the launch of its Amped Live Resin Liquid Diamond product line.

Tilray Brands shares staged a significant recovery Tuesday afternoon, jumping some 12%.

Don't bet on it.

A financial engineering move and an analyst's price target cut dampened sentiment on the company.

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.

It may be time for investors to cut their losses.

At one point this year, the cannabis producer's stock was up as much as 58%.

continued downward momentum comes one day after the cannabis and consumer packaged goods company began trading on a split-adjusted basis.

Tilray Brands Inc (NASDAQ:TLRY) shares are trending Tuesday as the stock begins trading on a split-adjusted basis.